Lion Point Capital as of March 31, 2026
Portfolio Holdings for Lion Point Capital
Lion Point Capital holds 35 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Praxis Precision Medicines I Com New (PRAX) | 8.6 | $1.4M | 4.5k | 322.19 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 7.5 | $1.3M | 68k | 18.64 | |
| Royalty Pharma Shs Class A (RPRX) | 6.1 | $1.0M | 21k | 47.97 | |
| Milestone Pharmaceuticals (MIST) | 5.8 | $976k | 820k | 1.19 | |
| Geron Corporation (GERN) | 5.1 | $861k | 578k | 1.49 | |
| Syndax Pharmaceuticals (SNDX) | 5.0 | $841k | 36k | 23.36 | |
| Ardelyx (ARDX) | 4.6 | $771k | 129k | 5.99 | |
| Fennec Pharmaceuticals (FENC) | 4.1 | $692k | 112k | 6.15 | |
| Benitec Biopharma Com New (BNTC) | 3.9 | $660k | 62k | 10.65 | |
| Sarepta Therapeutics (SRPT) | 3.7 | $620k | 29k | 21.76 | |
| Disc Medicine (IRON) | 3.1 | $518k | 8.1k | 63.94 | |
| Cue Biopharma (CUE) | 3.0 | $506k | 2.2M | 0.23 | |
| Compass Pathways Sponsored Ads (CMPS) | 2.6 | $442k | 80k | 5.53 | |
| Biohaven (BHVN) | 2.6 | $437k | 52k | 8.46 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 2.5 | $417k | 5.5k | 75.85 | |
| Jasper Therapeutics Com New (JSPR) | 2.4 | $407k | 465k | 0.88 | |
| Humacyte (HUMA) | 2.4 | $394k | 650k | 0.61 | |
| Viatris (VTRS) | 2.2 | $374k | 28k | 13.51 | |
| Kura Oncology (KURA) | 2.2 | $374k | 46k | 8.13 | |
| Bridgebio Pharma (BBIO) | 2.2 | $371k | 5.0k | 74.26 | |
| Dyne Therapeutics (DYN) | 2.0 | $326k | 18k | 18.13 | |
| Rocket Pharmaceuticals (RCKT) | 1.8 | $308k | 86k | 3.58 | |
| Pacira Pharmaceuticals (PCRX) | 1.8 | $305k | 14k | 22.60 | |
| Edgewise Therapeutics (EWTX) | 1.7 | $287k | 9.1k | 31.50 | |
| Mineralys Therapeutics (MLYS) | 1.7 | $284k | 11k | 27.09 | |
| Seres Therapeutics Com New (MCRB) | 1.7 | $280k | 32k | 8.87 | |
| Janux Therapeutics (JANX) | 1.6 | $264k | 19k | 13.90 | |
| Uniqure Nv SHS (QURE) | 1.4 | $240k | 15k | 16.35 | |
| Regenxbio Inc equity us cm (RGNX) | 1.3 | $223k | 27k | 8.38 | |
| Brooks Automation (AZTA) | 1.2 | $205k | 9.7k | 21.13 | |
| Innoviva (INVA) | 1.1 | $191k | 8.2k | 23.30 | |
| Gh Research Ordinary Shares (GHRS) | 0.9 | $143k | 10k | 14.06 | |
| Arcutis Biotherapeutics (ARQT) | 0.7 | $124k | 5.3k | 23.56 | |
| Innate Pharma S A Sponsored Ads (IPHA) | 0.6 | $104k | 81k | 1.28 | |
| Spruce Biosciences Com New (SPRB) | 0.4 | $65k | 1.0k | 65.35 |
